Veloxis Pharmaceuticals A/S
Latest round
- Series C
Last raised
- May 2005
Total raised
- $18M
Investors
- 5
About Veloxis Pharmaceuticals A/S
Founded in 2007, Veloxis Pharmaceuticals A/S, located in Copenhagen, Denmark, specializes in creating therapies for the transplant healthcare sector. The company was co-founded by Mohammad Sohail.00 mn, marking a significant milestone in its operational strategy.Veloxis Pharmaceuticals focuses on developing innovative therapies aimed at improving transplant healthcare for both providers and patients. Its flagship product, pegrizeprument (VEL-101), acts as a subcutaneous CD28 co-stimulation blocker for maintenance immunosuppression in kidney transplantation. This investigational drug addresses the challenges of effective immunosuppressive therapies, targeting hospitals and clinics that specialize in organ transplants.In 2022, Veloxis Pharmaceuticals reported zero revenue, while in 2023, it recorded an EBITDA of DKK -214,000. The company's revenue model is primarily based on the sale of its investigational immunosuppressive drug, pegrizeprument, through partnerships with healthcare providers, including transplant centers.Veloxis Pharmaceuticals aims to expand its product offerings and market reach, particularly through the development of new therapies designed for transplant patients. The exit of Adamant Biomedical Investments AG and Alta Partners from their stake suggests a strategic repositioning within the market, facilitating new opportunities for future initiatives.
Who invested in Veloxis Pharmaceuticals A/S
5 investors across 1 round
See all investors in Veloxis Pharmaceuticals A/S
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
May 17, 2005
Amount
$18M
Investors
Questions about Veloxis Pharmaceuticals A/S
Who invested in Veloxis Pharmaceuticals A/S?
Veloxis Pharmaceuticals A/S has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Veloxis Pharmaceuticals A/S raised?
Veloxis Pharmaceuticals A/S has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Veloxis Pharmaceuticals A/S last raise money?
Veloxis Pharmaceuticals A/S's most recent round on record is a Series C, in May 2005.
What does Veloxis Pharmaceuticals A/S do?
Founded in 2007, Veloxis Pharmaceuticals A/S, located in Copenhagen, Denmark, specializes in creating therapies for the transplant healthcare sector.
Where is Veloxis Pharmaceuticals A/S headquartered?
Veloxis Pharmaceuticals A/S is headquartered in Copenhagen, Denmark.
Which VCs invest in companies like Veloxis Pharmaceuticals A/S?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Veloxis Pharmaceuticals A/S's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Veloxis Pharmaceuticals A/S? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.